Organización Sanitaria Integrada Goierri-Urola Garaia
Organización de Osakidetza
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Murcia, EspañaPublications en collaboration avec des chercheurs de Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (11)
2021
-
Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer
Clinical Nutrition, Vol. 40, Núm. 4, pp. 1537-1545
-
Mediterranean diet and risk of dementia and alzheimer’s disease in the epic-spain dementia cohort study
Nutrients, Vol. 13, Núm. 2, pp. 1-19
-
Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study
Scientific Reports, Vol. 11, Núm. 1
2020
-
Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, Vol. 146, Núm. 12, pp. 3267-3280
-
Incidence of Dementia and Associated Factors in the EPIC-Spain Dementia Cohort
Journal of Alzheimer's Disease, Vol. 78, Núm. 2, pp. 543-555
-
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort
International Journal of Cancer, Vol. 147, Núm. 8, pp. 2042-2052
2019
-
Dietary inflammatory index, dietary non-enzymatic antioxidant capacity, and colorectal and breast cancer risk (MCC-Spain study)
Nutrients, Vol. 11, Núm. 6
-
Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study
Clinical Gastroenterology and Hepatology, Vol. 17, Núm. 7, pp. 1323-1331.e6
-
Moderate egg consumption and all-cause and specific-cause mortality in the Spanish European Prospective into Cancer and Nutrition (EPIC-Spain) study
European Journal of Nutrition, Vol. 58, Núm. 5, pp. 2003-2010
2018
-
Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1289-1301
-
Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: Results from the EPIC cohort
BMC Cancer, Vol. 18, Núm. 1